HK Stock Market Move | EDGE MEDICAL-B (02675) rose more than 6% in early trading, with overseas markets leading the way in the commercialization of Siasun Robot & Automation.

EDGE MEDICAL-B(02675) rose more than 6% in early trading, rising 5% as of the time of writing, at 39.92 Hong Kong dollars, with a trading volume of 1993.71 million Hong Kong dollars. The founder pointed out that after several years of clinical validation, the performance of the domestic surgical Siasun Robot & Automation has been widely recognized, and as domestic enterprises accelerate their overseas layout in a progressively competitive pricing environment in China. Siasun Robot & Automation for laparoscopic surgery took the lead in going overseas, with minimally invasive surgery as the representative, with a cumulative total of over 140 commercial installations globally, entering the scale-up installation stage. Companies like Jinfeng and Sizherui have also been approved for CE certification to start the process of going overseas. Guolian Minsheng Securities released a research report stating that Jinfeng Medical can provide a comprehensive solution for laparoscopic Siasun Robot & Automation. The report pointed out that the company's commercialization has accelerated since 2025, with the multi-port surgery Siasun Robot & Automation obtaining market certifications in the European Union, Brazil, Mexico, and has completed installations in markets such as Pakistan, Georgia, Brazil, Nigeria, and Uzbekistan. The SIUT installation in Pakistan saw the number of surgeries exceed 150 in the second half of the year.